Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Alcoholic Intoxication, Chronic
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
0.040 GeneticVariation BEFREE We have screened 200 Japanese workers and 105 Japanese patients with alcoholism for the mutation in the signal peptide of pre-pro-neuropeptide Y resulting in a substitution of proline for leucine at position 7. 11409703 2001
Alcoholic Intoxication, Chronic
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
0.040 GeneticVariation BEFREE Recent studies have provided evidence for an association between a Leu7Pro polymorphism, as well as 2 promoter single nucleotide polymorphisms (SNPs) in the NPY gene (G-602T, T-399C) and alcohol dependence. 18241322 2008
Alcoholic Intoxication, Chronic
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
0.040 GeneticVariation BEFREE NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations. 12544000 2003
Alcoholic Intoxication, Chronic
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
0.040 GeneticVariation BEFREE A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. 12215082 2002
Anxiety
CUI: C0003467
Disease: Anxiety
0.010 GeneticVariation BEFREE Leu7Pro was analyzed in a large well-characterized longitudinal population-based sample of adult Swedes with data on life situation and life history, including 461 with depression diagnosis, 157 with anxiety diagnosis and 1514 healthy individuals with no symptom of psychopathology. 19264362 2009
Anxiety Disorders
CUI: C0003469
Disease: Anxiety Disorders
0.010 GeneticVariation BEFREE Leu7Pro was analyzed in a large well-characterized longitudinal population-based sample of adult Swedes with data on life situation and life history, including 461 with depression diagnosis, 157 with anxiety diagnosis and 1514 healthy individuals with no symptom of psychopathology. 19264362 2009
Arteriosclerosis
CUI: C0003850
Disease: Arteriosclerosis
0.040 GeneticVariation BEFREE The results indicate significant associations between inflammatory cell activation in blood and vascular atherosclerosis in genetically prone subjects, and provide possible mechanistic information about the role of NPY and the Leu7Pro polymorphism in the development of atherosclerosis. 21746772 2011
Arteriosclerosis
CUI: C0003850
Disease: Arteriosclerosis
0.040 GeneticVariation BEFREE The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases. 18043699 2009
Arteriosclerosis
CUI: C0003850
Disease: Arteriosclerosis
0.040 GeneticVariation BEFREE In this study, we investigated the role of two functional NPY polymorphisms, NPY-Leu7Pro (rs16139) and NPY-399C/T (rs16147) and obesity for the development of asthma as well as atherosclerosis in asthmatic and non-asthmatic subjects. 23122776 2012
Arteriosclerosis
CUI: C0003850
Disease: Arteriosclerosis
0.040 GeneticVariation BEFREE A rather common leucine7-to-proline7 (Leu7Pro) polymorphism in the preproneuropeptide Y (prepro-NPY) gene signal peptide may be important in blood pressure regulation, cholesterol metabolism and the pathogenesis of atherosclerosis in humans. 11689216 2001
Asthma
CUI: C0004096
Disease: Asthma
0.010 GeneticVariation BEFREE In this study, we investigated the role of two functional NPY polymorphisms, NPY-Leu7Pro (rs16139) and NPY-399C/T (rs16147) and obesity for the development of asthma as well as atherosclerosis in asthmatic and non-asthmatic subjects. 23122776 2012
Atherosclerosis
CUI: C0004153
Disease: Atherosclerosis
0.040 GeneticVariation BEFREE The leucine7 to proline7 (Leu7Pro) polymorphism in preproneuropeptide Y (preproNPY) has been associated with accelerated atherosclerosis and type II diabetes, both of which are obesity-related diseases. 18043699 2009
Atherosclerosis
CUI: C0004153
Disease: Atherosclerosis
0.040 GeneticVariation BEFREE A rather common leucine7-to-proline7 (Leu7Pro) polymorphism in the preproneuropeptide Y (prepro-NPY) gene signal peptide may be important in blood pressure regulation, cholesterol metabolism and the pathogenesis of atherosclerosis in humans. 11689216 2001
Atherosclerosis
CUI: C0004153
Disease: Atherosclerosis
0.040 GeneticVariation BEFREE The results indicate significant associations between inflammatory cell activation in blood and vascular atherosclerosis in genetically prone subjects, and provide possible mechanistic information about the role of NPY and the Leu7Pro polymorphism in the development of atherosclerosis. 21746772 2011
Atherosclerosis
CUI: C0004153
Disease: Atherosclerosis
0.040 GeneticVariation BEFREE In this study, we investigated the role of two functional NPY polymorphisms, NPY-Leu7Pro (rs16139) and NPY-399C/T (rs16147) and obesity for the development of asthma as well as atherosclerosis in asthmatic and non-asthmatic subjects. 23122776 2012
Cardiovascular Diseases
CUI: C0007222
Disease: Cardiovascular Diseases
0.030 GeneticVariation BEFREE Therefore, we investigated the impact of the Leu7Pro polymorphism on diabetic nephropathy, cardiovascular risk factors, and cardiovascular disease in type 1 diabetic patients. 14747236 2004
Cardiovascular Diseases
CUI: C0007222
Disease: Cardiovascular Diseases
0.030 GeneticVariation BEFREE SNP association studies using p.L7P polymorphism suggest that this functional substitution may be a strong independent risk factor for various metabolic and cardiovascular diseases. 18499283 2008
Cardiovascular Diseases
CUI: C0007222
Disease: Cardiovascular Diseases
0.030 GeneticVariation BEFREE The Leu7Pro substitution has been linked to cardiovascular disease, but it is unknown whether the Pro7 allele is associated with increased or decreased risk of coronary heart disease (CHD). 18054939 2008
Carotid Atherosclerosis
CUI: C0577631
Disease: Carotid Atherosclerosis
0.010 GeneticVariation BEFREE Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects. 10852461 2000
Complications of Diabetes Mellitus
CUI: C0342257
Disease: Complications of Diabetes Mellitus
0.010 GeneticVariation BEFREE Since no impact of preproNPY genotype on mean NPY or hormone levels were detected in subjects with type 2 diabetes, the mechanisms for the increased risk for diabetic complications in the subjects with the Leu7Pro polymorphism need to be further explored. 17516289 2007
Coronary Arteriosclerosis
CUI: C0010054
Disease: Coronary Arteriosclerosis
0.050 GeneticVariation BEFREE Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients. 14747236 2004
Coronary Arteriosclerosis
CUI: C0010054
Disease: Coronary Arteriosclerosis
0.050 GeneticVariation BEFREE The aim of the present study was to investigate the association of the Leu7Pro polymorphism with coronary atherosclerosis and its consequences. 18054939 2008
Coronary Arteriosclerosis
CUI: C0010054
Disease: Coronary Arteriosclerosis
0.050 GeneticVariation BEFREE Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease. 11914038 2002
Coronary Arteriosclerosis
CUI: C0010054
Disease: Coronary Arteriosclerosis
0.050 GeneticVariation BEFREE Neuropeptide Y Leu7Pro polymorphism associated with the metabolic syndrome and its features in patients with coronary artery disease. 22308535 2013
Coronary Arteriosclerosis
CUI: C0010054
Disease: Coronary Arteriosclerosis
0.050 GeneticVariation BEFREE High frequency of Neuropeptide Y Leu7Pro polymorphism in an Iranian population and its association with coronary artery disease. 22289186 2012